Article

A novel intergenic region ALK fusion is targetable by alectinib in a non-small cell lung cancer patient with brain metastasis

2022-03-31

Abstract excerpt

ALK rearrangement defines a unique non-small cell lung cancer (NSCLC) molecular subtype, of which the patients could potentially benefit from anti- ALK therapies. So far, the outcomes of the canonical EML-ALK patients subjected to ALK inhibitors are well established. However, given the increasing complexity of ALK fusion partners, as detected by high-throughput sequencing, the responses of those with rare ALK fusi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6d49ef74-e2f9-5b12-86b8-7360414af526
DOI: 10.21203/rs.3.rs-1492685/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A novel intergenic region ALK fusion is targetable by alectinib in a non-small cell lung cancer patient with brain metastasisDOI 10.21203/rs.3.rs-1492685/v1Read

Effective Treatment With Endostar and Crizotinib Sequential Alectinib in a Lung Adenocarcinoma Patient With Brain Metastases Harboring a Novel CLHC1/RNT4 Intergenic Region- ALK FusionSemantic proximity Read

ALK Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy.Semantic proximity Read

Uncovering Clinically Relevant Gene Fusions with Integrated Genomic and Transcriptomic Profiling of Metastatic CancersSemantic proximity Read

Clinically relevant fusion oncogenes: detection and practical implicationsSemantic proximity Read

Therapeutic Advances of Rare ALK Fusions in Non-Small Cell Lung CancerSemantic proximity Read

Complex ALK Fusions Are Associated With Better Prognosis in Advanced Non-Small Cell Lung CancerSemantic proximity Read

Catalog of 5’ Fusion Partners in ALK-positive NSCLC Circa 2020Semantic proximity Read

Molecular characteristics and clinical outcomes of complex ALK rearrangements identified by next-generation sequencing in non-small cell lung cancersSemantic proximity Read

Comprehensive Molecular and Clinicopathologic Analysis of 200 Pulmonary Invasive Mucinous Adenocarcinomas Identifies Distinct Characteristics of Molecular Subtypes.Semantic proximity Read

Exploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number dataSemantic proximity Read

STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case ReportSemantic proximity Read

Identification of MET fusions as novel therapeutic targets sensitive to MET inhibitors in lung cancer.Semantic proximity Read